Assam CM Addresses Concerns Over Cancer Treatment Costs

Clarification on Cancer Treatment Charges

Guwahati, Aug 13: In response to growing criticism regarding significant increases in cancer treatment fees at the State Cancer Institute, Assam's Chief Minister Himanta Biswa Sarma took steps to alleviate public concerns on Wednesday, asserting that there has been no rise in patient costs.

He characterized the situation as a “misunderstanding” and reassured that the government would continue to cover treatment expenses through existing health initiatives.

“There has been some confusion. Patients are not required to pay for cancer treatment. The government will cover these costs through Ayushman Bharat and Ayushman Assam. Even if there are adjustments to certain service rates, such as for general beds, patients will not be responsible for any additional charges as these will be managed under these health cards,” Sarma stated during a press conference in Kokrajhar.

The Chief Minister admitted that the previous decision to require a Rs 10,000 advance deposit from patients was a “mistake” and confirmed its cancellation.

“If we adjust the rates and receive funding from Delhi, which is then allocated for cancer patients, it should not pose any issues. This topic will also be on the agenda for today’s cabinet meeting,” he added.

Earlier, JP Prasad, Chief Operating Officer of the Assam Cancer Care Foundation (ACCF), mentioned that the changes were in accordance with government guidelines and that only minor adjustments had been made.

For instance, the registration fee has increased by just Rs 10, while the consultation fee remains at Rs 100 for a month, regardless of the number of visits.

“For diagnostic purposes, an MRI can be conducted for Rs 10. In contrast, under the Central Government Health Scheme, the consultation fee is Rs 350 and is valid for only 15 days,” he explained.

Regarding chemotherapy, Prasad noted that the costs are still quite low – Rs 2,800 for multi-drug cycles and Rs 2,300 for single-drug cycles, with most cycles priced between Rs 2,000 and Rs 2,500.

He added that bed and ICU rates have remained unchanged, at Rs 1,000 and Rs 2,000 per day, respectively.

“We operate as a not-for-profit entity and have no intention of placing additional burdens on patients,” Prasad emphasized, referring to the adjustments as a “trial process” that would be evaluated if necessary.

Prasad defended the rate changes, stating they were essential for maintaining hospital standards and ensuring efficient operations.

“Establishing a standardized fee structure is crucial for public trust. Patients with PMJAY (Pradhan Mantri Jan Arogya Yojana) or BPL (Below Poverty Line) cards will continue to receive full exemptions,” Prasad confirmed.

The government's clarification has provided reassurance to patients and their families who were distressed by earlier reports of steep price hikes.

Opposition parties and local organizations had criticized the state government over the alleged price increases.

“In light of the price hikes, I urge the government to create a cashless treatment process for those in need through the Assam Arogya Nidhi scheme, which offers financial support for life-threatening illnesses,” stated Leader of Opposition Debabrata Saikia.

While the origin of the “misunderstanding” regarding treatment costs remains unclear, the political and public backlash prompted quick clarifications from both the government and the ACCF.